Clinical Trial Update: A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating atezolizumab with or without bevacizumab in patients with unresectable hepatocellular carcinoma and Child-Pugh B7/B8 cirrhosis; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING